You are here

Batch release assessment of COVID-19 vaccines

27 June 2022

The Therapeutic Goods Administration (TGA) ensures there is an independent quality assessment of every batch of vaccine supplied in Australia. This page provides information about the batch release assessment process for COVID-19 vaccines.

What is batch release assessment?

During the evaluation process for provisional registration, the TGA reviews data to confirm that the manufacturing process is well controlled and sets up how the quality of the vaccine will be maintained in future batches.

To ensure these standards are maintained, the TGA will conduct a batch release assessment process for every batch of vaccine supplied in Australia. Every vaccine batch must pass the assessment before it is released for use.

A batch release assessment involves one or both of the following steps:

  1. A review of documents supplied by the Sponsor which describe the manufacturing process (how the vaccine is made, tested, shipped and stored)
  2. TGA laboratory testing (and/or review of testing results from an overseas regulatory laboratory that has been recognised by the TGA) to ensure the vaccine has been manufactured according to the required standards

The TGA's laboratory may carry out a range of tests, including assessments for composition, identity, potency, purity and adventitious agents (contamination with microorganisms).

Batch release assessment is a critical part of the regulatory oversight of vaccine quality. It is especially important for vaccines that are provisionally approved, such as COVID-19 vaccines.

What will the TGA do for COVID-19 vaccine batch release?

COVID-19 vaccines will have a priority release schedule. One of two release pathways will be undertaken:

  • Pathway one - release based on overseas certification
  • Pathway two - release based on TGA laboratory assessment.

Pathway one - Release based on overseas certification

Pathway one uses overseas certification as evidence that the batch has already undergone independent testing and assessment by a recognised National Control Laboratory, such as the Official Control Authority Batch Release (OCABR) process in Europe.

The OCABR process involves assessment of manufacturing documentation (summary protocol review) and laboratory testing for potency, identity and appearance based on guidelines for specific COVID-19 vaccine types (e.g. RNA, viral vector, and inactivated vaccines).

When the Sponsor provides evidence that the batch supplied in Australia has passed OCABR testing, the vaccine can be released without the TGA conducting a manufacturing protocol assessment or (potentially) laboratory testing.

The Sponsor must still supply samples, batch details and evidence of the maintenance of adequate shipping conditions for the batch under this pathway.

OCABR certificates are unlikely to be available for all COVID-19 vaccine batches as their availability depends on many factors, including the final global distribution of a batch.

Pathway two - Release based on TGA assessment

Pathway two is used when no OCABR Certificate is available. In this case release of the vaccine is based upon TGA review of the manufacturing summary protocol and shipping information and testing in the TGA Laboratories.

TGA Laboratories testing results for COVID-19 vaccines

TGA Laboratories have been performing batch release and testing on all batches of COVID-19 vaccines that have been supplied in Australia. Batch release assessment is a critical part of the regulatory oversight of vaccine quality. It is especially important for vaccines that are provisionally approved, such as COVID-19 vaccines.

The information available covers all COVID-19 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine.

The table of information will be regularly updated as additional batches are assessed.

ARTG ID ARTG entry name Batch Batch release date Composition and strength result Purity and integrity result Identity result Endotoxin result Remarks
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 2100708* 26/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 344547P 23/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 344548P 23/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 344545P 21/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 344546P 21/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 344543P 16/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 344544P 16/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 343437P 15/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 344542P 15/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 343432P 9/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 343433P 9/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 343434P 9/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 341224P 8/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 342524P 7/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 342522P 1/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 342523P 1/06/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 342520P 31/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 342521P 31/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 341223P 26/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 342519P 26/05/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial SDYY2* 26/05/2022 In progress Passed In progress Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 341221P 24/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 341222P 24/05/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 36715TB* 19/05/2022 In progress Passed In progress Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 204003* 19/05/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 8002107* 19/05/2022 In progress In progress In progress In progress N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial SDYY1* 19/05/2022 In progress Passed In progress Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 341220P 18/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 341219P 17/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 340635P 12/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 340636P 12/05/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FW1123* 11/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 340632P 9/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 340633P 9/05/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 8000005* 9/05/2022 In progress In progress In progress In progress N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 204002* 6/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339975P 5/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 340631P 5/05/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FY0636* 5/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339974P 4/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339970P 3/05/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339970P1 3/05/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FW5101* 2/05/2022 In progress In progress In progress In progress N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 35627TB* 29/04/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 36644TB* 29/04/2022 Passed Passed Passed Passed N/A
355139 NUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial 4302MF011* 28/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339973P 28/04/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 36642TB* 27/04/2022 In progress In progress In progress In progress N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 220102* 26/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339971P 26/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339972P 26/04/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 8001803* 26/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 335215P 22/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339015P 22/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339017P 22/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339018P 22/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 335214P 21/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 335216P 21/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 339016P 21/04/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FW0201* 21/04/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 36678TB* 13/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 335211P 12/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 335212P 12/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 335213P 12/04/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCA0077* 7/04/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCA0080* 7/04/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 331220P 5/04/2022 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 2100695* 4/04/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FR4268* 1/04/2022 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 8000898* 31/03/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 8001016* 31/03/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FW4423* 28/03/2022 In progress In progress In progress In progress N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 8000281* 25/03/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 8005036* 25/03/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FN4074* 23/03/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 8004962* 22/03/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 8004976* 21/03/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 1F1058A* 18/03/2022 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 2100698* 18/03/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FR4268* 18/03/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCB0020* 16/03/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 1F1057A* 4/03/2022 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 1F1057A* 3/03/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 1F1056A* 24/02/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 211172* 24/02/2022 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCA0065* 18/02/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCA0074* 18/02/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCB0009* 18/02/2022 Passed Passed Passed Passed N/A
355139 NUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial 4301MF005* 15/02/2022 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 2100691* 15/02/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCA0057* 9/02/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial PCA0068* 9/02/2022 Passed Passed Passed Passed N/A
355139 NUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial 4301MF004* 8/02/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FR8392* 8/02/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 8000010* 3/02/2022 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 2100688* 27/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 211172* 25/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 1F1045A* 24/01/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FN4073* 24/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 331215P 20/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 331216P 20/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 331218P 20/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 1F1030A* 19/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 211067* 19/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328875P 19/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 331210P 13/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 331214P 13/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328874P 11/01/2022 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 2100690* 11/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 211065* 10/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 211071* 10/01/2022 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FP8290* 10/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 210957* 6/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328872P 4/01/2022 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328873P 4/01/2022 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial 211069* 31/12/2021 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FN4075* 31/12/2021 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FP9643* 31/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 327568P 21/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328866P 21/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328867P 21/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328868P 21/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328869P 21/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328033P1 20/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328426P 16/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328865P 16/12/2021 Passed Passed Passed Passed N/A
377111 COMIRNATY (tozinameran COVID-19 VACCINE 10 micrograms/0.2 mL  concentrated suspension for injection vial FP1430* 16/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328425P 14/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328862P 14/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 326914P 9/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328033P 9/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 328423P 9/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 327569P 7/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 327570P 7/12/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000098A* 4/12/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000099A* 4/12/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000062A* 3/12/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 326913P 2/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 327567P 2/12/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 326912P 30/11/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000064A* 26/11/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000069A* 26/11/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FL4210* 25/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 326911P 23/11/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FN0565* 22/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 326571P 18/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 326572P 18/11/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FK0892* 18/11/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FK9707* 15/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325921P 11/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325922P 11/11/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FK0738* 10/11/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000062A* 9/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325917P 9/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325919P 9/11/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FL3560* 5/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325712P 4/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325920P 4/11/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FL5333* 4/11/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000053A* 3/11/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000055A* 3/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325710P 2/11/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325711P 2/11/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000047A* 28/10/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000052A* 28/10/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000053A* 28/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325699P 28/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325709P 28/10/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FK6268* 27/10/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FL5729* 26/10/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000046A* 21/10/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000052A* 21/10/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FL7649* 21/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324007P 19/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325371P 19/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325372P 19/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325369P 14/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 325370P 14/10/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000045A* 13/10/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000046A* 13/10/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FH3221* 13/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324905P 12/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324907P 12/10/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000045A* 8/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324408P 7/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324906P 7/10/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FK6858* 7/10/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000031A* 5/10/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324406P 5/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324410P1 5/10/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324411P 5/10/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG6431* 5/10/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3712* 1/10/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3716* 1/10/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000016A* 30/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3716* 29/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FJ5973* 29/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324006P 28/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324407P 28/09/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000031A* 27/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3712* 27/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3716* 27/09/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 3006325* 24/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 3006325* 24/09/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 3006329* 24/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 3006329* 24/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3712* 24/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 323125P 22/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 323180P 22/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 324005P 22/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FH3219* 22/09/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000016A* 21/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3712* 20/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000002A* 19/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 3005842* 19/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3712* 17/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 323179P 15/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FH3253* 15/09/2021 Passed Passed Passed Passed N/A
370599 SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial 000002A* 14/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3712* 14/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG3712* 14/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 323123P 13/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 323124P 13/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FF8222* 10/09/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 322679P 9/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 323120P 9/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FJ8372* 8/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 322675P 7/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 322676P 7/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FH0160* 6/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FF8222* 4/09/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG1657* 4/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 322673P 2/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 322673P1 2/09/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 321880P 30/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 321881P 30/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 321875P 24/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 321879P 24/08/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FH4092* 24/08/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG7372* 19/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319751P 17/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319752P 17/08/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FE7051* 16/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319748P 12/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319749P 12/08/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FF0884* 12/08/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks OCABR Reviewed. Limited batch quantity allocated for use in Pfizer Australia employee vaccination program
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319694P 10/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319747P 10/08/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FF4206* 10/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319692P 6/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial NJ0240* 4/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319691P 3/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 319693P 3/08/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FE8163* 3/08/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317709P 30/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317710P 30/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317711P 30/07/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FA4598* 30/07/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks OCABR Reviewed. Limited batch quantity allocated for use in Pfizer Australia employee vaccination program
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317707P 29/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317708P 29/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317706P 28/07/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FG0050* 27/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317705P 15/07/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FF0884* 15/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 317704P 14/07/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FE3430* 14/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 314120P 6/07/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FF4222* 6/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308980P 2/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 314119P 2/07/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308978P 29/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FC5029* 29/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FE3064* 25/06/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks OCABR Reviewed. Limited batch quantity allocated for use in Pfizer Australia employee vaccination program
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308979P 24/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FE3064* 23/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308968P 22/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308977P 22/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FA7338* 22/06/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks OCABR Reviewed. Limited batch quantity allocated for use in Pfizer Australia employee vaccination program
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FA7812* 22/06/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks OCABR Reviewed. Limited batch quantity allocated for use in Pfizer Australia employee vaccination program
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FC8736* 22/06/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks OCABR Reviewed. Limited batch quantity allocated for use in Pfizer Australia employee vaccination program
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FC3558* 21/06/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks OCABR Reviewed. Limited batch quantity allocated for use in Pfizer Australia employee vaccination program
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308966P 17/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308967P 17/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FE2090* 17/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308586P 15/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FD9234* 10/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FA5833* 9/06/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FA5833* 9/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FC2336* 9/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308584P 8/06/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FD0927* 7/06/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308582P 3/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308583P 3/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 306731P 1/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 308178P 1/06/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305954P 27/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 306730P 27/05/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FD0927* 27/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305953P 25/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305955P 25/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305595P 20/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305952P 20/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 304857P 18/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305593P 18/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305594P 14/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 305592P 13/05/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial FC3558* 13/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 304219P 11/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 304220P 11/05/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial EX6564* 7/05/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 303816P 4/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 304217P 4/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 304218P 4/05/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 303604P 29/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 303814P 27/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 303815P 27/04/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial EX6564* 22/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 302933P 20/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 302935P 20/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 302930P 15/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 302365P 13/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 302363P 12/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 302363P1 12/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 301779P 8/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 302359P 8/04/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial EX2405* 8/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 300165P 1/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 301777P 1/04/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 301778P 1/04/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial ET3045* 30/03/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 300157P 23/03/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 300158P 23/03/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 300160P 23/03/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial 300161P 23/03/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial ER7449* 22/03/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial PW40043* 13/03/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial EX6564* 1/03/2021 Not tested - see remarks Not tested - see remarks Not tested - see remarks Not tested - see remarks Additional shipment
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial PV46672* 1/03/2021 Passed Passed Passed Passed N/A
349072 VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial PW40038* 1/03/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial ER7449* 27/02/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial EP9605* 12/02/2021 Passed Passed Passed Passed N/A
346290 COMIRNATY (tozinameran COVID-19 VACCINE 30 micrograms/0.3 mL concentrated suspension for injection vial EP2163* 9/02/2021 Passed Passed Passed Passed N/A

*internationally manufactured batches